Raynaud's disease - Clinical trials 

Clinical trials for Raynaud's phenomenon

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Raynaud's phenomenon. For all clinical trials, go to clinical trials search

This list shows clinical trials for Raynaud's phenomenon

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Raynaud's phenomenon
Title Recruitment status Location
Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon Not recruiting United Kingdom
Phase III “In-Life” Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud’s Phenomenon - 06-004 A2 Not Recruiting United Kingdom
Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon Not recruiting United Kingdom
A study of ORM-12741 for the prevention of blood vessel spasm brought on by cold temperature. Authorised United Kingdom
Phase III “In-Life” Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud’s Phenomenon - 06-004 A2 Authorised United Kingdom
Topical Amlodipine in Raynaud's Phenomenon Authorised United Kingdom
A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in the management of Raynaud’s phenomenon. - Asasantin retard therapy in the management of Raynaud's phenomenon Authorised United Kingdom
Prognostic Influence of Light Rheography Measurement of Patients With Secundary Raynaud Syndrome With Ulcers on Hands Recruiting Germany
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon Recruiting Korea, Republic of
MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison Recruiting United States